Helicobacter pylori Infection increases insulin resistance and metabolic syndrome in residents younger than 50 years old: A community-based study

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Chen, Li Wei ^a   Chien, Chih Yi ^a   Yang, Kai Jie ^a   Kuo, Sheng Fong ^a   Chen, Chih Hung ^a   Chien, Rong Nan ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; C REACTIVE PROTEIN; INSULIN; LEPTIN; SUGAR; TUMOR NECROSIS FACTOR ALPHA; BACTERIUM ANTIBODY;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; GROUPS BY AGE; HELICOBACTER INFECTION; HUMAN; HYPERTENSION; IMMUNOASSAY; INCIDENCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREDICTION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SHORT FORM 36; SYSTOLIC BLOOD PRESSURE; TAIWAN; VERY ELDERLY; YOUDEN INDEX; AGE; BLOOD; CASE CONTROL STUDY; CLINICAL TRIAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; MICROBIOLOGY; PATHOPHYSIOLOGY;

HELICOBACTER PYLORI;

AGE FACTORS; AGED; ANTIBODIES, BACTERIAL; CASE-CONTROL STUDIES; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; HYPERTENSION; INSULIN RESISTANCE; LEPTIN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; TAIWAN;

EID: 84932612852     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0128671     Document Type: Article

References (42)

1. Crabtree JE (1996) Gastric mucosal inflammatory responses to Helicobacter pylori. Aliment Pharmacol Ther 10 (Suppl 1): 29-37. PMID: 8730257
2. Ernst PB, Jin Y, Reyes VE, Crowe SE (1994) The role of the local immune response in the pathogenesis of peptic ulcer formation. Scand J Gastroenterol 205 (Suppl 1): 22-28.
3. Kusters JG, van Vliet AH, Kuipers EJ (2006) Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 19: 449-490. PMID: 16847081
4. Moss SF, Legon S, Davies J, Calam J (1994) Cytokine gene expression in Helicobacter pylori associated antral gastritis. Gut 35: 1567-1570. PMID: 7828974
5. Thalmaier U, Lehn N, Pfeffer K, Stolte M, Vieth M, Schneider-BrachertW(2002) Role of tumor necrosis factor alpha in Helicobacter pylori gastritis in tumor necrosis factor receptor 1-deficient mice. Infect Immun 70: 3149-3155. PMID: 12011009
6. Noach LA, Bosma NB, Jansen J, Hoek FJ, van Deventer SJ, Tytgat GN (1994) Mucosal tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8 production in patients with Helicobacter pylori infection. Scand J Gastroenterol 29: 425-429. PMID: 8036458
7. Breidert M, Miehlke S, Glasow A, Orban Z, Stolte M, Ehninger G, et al (1999) Leptin and its receptor in normal human gastric mucosa and in Helicobacter pylori-associated gastritis. Scand J Gastroenterol 34: 954-961. PMID: 10563663
8. Azuma T, Suto H, Ito Y, Ohtani M, Dojo M, Kuriyama M, et al (2001) Gastric leptin and Helicobacter pylori infection. Gut 49: 324-329. PMID: 11511551
9. Roper J, Francois F, Shue PL, Mourad MS, Pei Z, Olivares de Perez AZ, et al (2008) Leptin and ghrelin in relation to Helicobacter pylori status in adult males. J Clin Endocrinol Metab 93: 2350-2357. doi: 10. 1210/jc.2007-2057 PMID: 18397989
10. Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factoralpha: direct role in obesity-linked insulin resistance. Science 259: 87-91. PMID: 7678183
11. Cohen B, Novick D, Rubinstein M (1996) Modulation of insulin activities by leptin. Science 274: 1185-1188. PMID: 8895466
12. Matthaei S, Stumvoll M, Kellerer M, Häring HU (2000) Pathophysiology and pharmacological treatment of insulin resistance. Endocr Rev 21: 585-618. PMID: 11133066
13. Shoelson SE, Herrero L, Naaz A (2007) Obesity, inflammation, and insulin resistance. Gastroenterol 132: 2169-2180. PMID: 17498510
14. Ferrannini E, Haffner SM, Mitchell BD, Stern MP (1991) Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34: 416-422. PMID: 1884900
15. Aydemir S, Bayraktaroglu T, Sert M, Sokmen C, Atmaca H, Mungan G, et al (2005) The effect of Helicobacter pylori on insulin resistance. Dig Dis Sci 50: 2090-2093. PMID: 16240220
16. Aslan M, Horoz M, Nazligul Y, Bolukbas C, Bolukbas FF, Selek S, et al (2006) Insulin resistance in H pylori infection and its association with oxidative stress. World J Gastroenterol 12: 6865-6868. PMID: 17106938
17. Candelli M, Rigante D, Marietti G, Nista EC, Crea F, Bartolozzi F, et al (2003) Helicobacter pylori, gastrointestinal symptoms, and metabolic control in young type 1 diabetes mellitus patients. Pediatr 111: 800-803.
18. Gunji T, Matsuhashi N, Sato H, Fujibayashi K, Okumura M, Sasabe N, et al (2008) Helicobacter pylori infection is significantly associated with metabolic syndrome in the Japanese population. Am J Gastroenterol 103: 3005-3010. doi: 10.1111/j.1572-0241.2008.02151.x PMID: 19086952
19. Gunji T, Matsuhashi N, Sato H, Fujibayashi K, Okumura M, Sasabe N, et al (2009) Helicobacter pylori infection significantly increases insulin resistance in the asymptomatic Japanese population. Helicobacter 14: 144-150. doi: 10.1111/j.1523-5378.2009.00705.x PMID: 19751440
20. Polyzos SA, Kountouras J, Zavos C, Deretzi G (2011) The association between Helicobacter pylori infection and insulin resistance: A systematic review. Helicobacter 16: 79-88. doi: 10.1111/j.1523-5378. 2011.00822.x PMID: 21435084
21. Albaker WI (2011) Helicobacter pylori infection and its relationship to metabolic syndrome: is it a myth or fact? Saudi J Gastroenterol 17: 165-169. doi: 10.4103/1319-3767.80377 PMID: 21546717
22. Naja F, Nasreddine L, Hwalla N, Moghames P, Shoaib H, Fatfat M, et al (2012) Association of H. pylori infection with insulin resistance and metabolic syndrome among Lebanese adults. Helicobacter 17: 444-451. doi: 10.1111/j.1523-5378.2012.00970.x PMID: 23066847
23. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001) Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285: 2486-2497. PMID: 11368702
24. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 112: 2735-2752. PMID: 16157765
25. Alberti KGMM, Zimmet P, Shaw J (2006) Metabolic syndrome-a new world-wide definition.A consensus statement from the international diabetes federation. Diabet Med 23: 469-480. PMID: 16681555
26. Alberti KGMM, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group (2005) The metabolic syndrome-a new worldwide definition. Lancet 366: 1059-1062. PMID: 16182882\
27. Saad MAN, Cardoso GP, Martins WdeA, Velarde LG, da Cruz Filho RA (2014) Prevalence of metabolic syndrome in elderly and agreement among four diagnostic criteria. Arq Bras Cardiol 102: 263-269. PMID: 24676226
28. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419. PMID: 3899825
29. Gayoso-Diz P, Otero-González A, Rodriguez-Alvarez MX, Gude F, García F, García F, et al (2013) Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study. BMC Endocr Disord 13: 47-57. doi: 10.1186/1472-6823-13-47 PMID: 24131857
30. Ware JE, Sherburne CD (1992) The MOS 36-item short-form healthy survey (SF-36). Med Care 30:473-483. PMID: 1593914
31. Tseng HM, Lu JR, Gandek B (2003) Cultural issues in using the SF-36 health survey in Asia: results from Taiwan. Health Qual Life Outcomes 1:72-81 PMID: 14641915
32. Tresaco B, Bueno G, Pineda I, Moreno LA, Garagorri JM, Bueno M (2005) Homeostatic model assessment (HOMA) index cut-off values to identify the metabolic syndrome in children. J Physiol Biochem 61: 381-388. PMID: 16180336
33. Gillum RF (2004) Infection with Helicobacter pylori, coronary heart disease, cardiovascular risk factors, and systemic inflammation: the third national health and nutrition examination survey. J Natl Med Assoc 96: 1470-1476. PMID: 15586651
34. Woodward M, Morrison C, McColl K (2000) An investigation into factors associated with Helicobacter pylori infection. J Clin Epidemiol 53: 175-181. PMID: 10729690
35. Cammarota G, Pasceri V, Gasbarrini A, Gasbarrini G (2000) Helicobacter pylori is an aetiological factor for ischaemic heart disease: the case against. Dig Liver Dis 32: 65-68. PMID: 10975758
36. Andraws R, Berger JS, Brown DL (2005) Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials. JAMA 293: 2641-2647. PMID: 15928286
37. Danesh J, Peto R (1998) Risk factors for coronary heart disease and infection with Helicobacter pylori: meta-analysis of 18 studies. BMJ 316: 1130-1132. PMID: 9552950
38. Sung KC, Rhee EJ, Ryu SH, Beck SH (2005) Prevalence of Helicobacter pylori infection and its association with cardiovascular risk factors in Korean adults. Int J Cardiol 102: 411-417. PMID: 16004885
39. Liston R, Pitt MA, Banerjee AK (1996) IgG ELISA antibodies and detection of Helicobacter pylori in elderly patients. Lancet. 347:269. PMID: 8551920
40. Kinjo K, Sato H, Sato H, Shiotani I, Kurotobi T, Ohnishi Y, et al (2002) Prevalence of Helicobacter pylori infection and its link to coronary risk factors in Japanese patients with acute myocardial infarction. Circ J 66: 805-810. PMID: 12224816
41. Kanbay M, Gür G, Yücel M, Yilmaz U, Boyacioglu S (2005) Does eradication of Helicobacter pylori infection help normalize serum lipid and CRP levels? Dig Dis Sci 50: 1228-1231. PMID: 16047464
42. Chimienti G, Russo F, Lamanuzzi BL, Nardulli M, Messa C, Di Leo A, et al (2003) Helicobacter pylori is associated with modified lipid profile: impact on lipoprotein(a). Clin Biochem 36: 359-365. PMID: 1284986